Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 256 results found. Search for [ COVID-19 vaccine trials China ]

Results 1 to 21 of 256
PTI
February 28, 2021
China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the US drug regulator


BusinessToday.In
February 24, 2021
Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week


Reuters
February 14, 2021
In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data


BusinessToday.In
New Delhi, February 3, 2021
Russia's COVID-19 vaccine, Sputnik V, has shown 91.6 per cent efficacy in phase 3 trials with no serious side effects, as per an interim analysis published in The Lancet Journal; Oxford Languages has named 'Aatmanirbharta' as its Hindi Word of the Year 2020; Alibaba Group founder Jack Ma has been delisted from \"Chinese entrepreneurial leaders\" list published by the country's official state media. Watch this and more on News Blast. Also Read: RBI releases framework for risk-based internal audit of NBFCs, UCBs


BusinessToday.In
February 2, 2021
The Gam-COVID-Vac, called Sputnik V, is a two-part vaccine that includes two adenovirus vectors - recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S).


Reuters
February 2, 2021
The firm obtained rights to supply the AZD1222 vaccine, developed by the Anglo-Swedish drugmaker and Oxford University, in mainland China last year in return for having capacity to produce at least 200 million doses by the end of 2021


Reuters
January 30, 2021
The review, of more than 40 publicly available documents and research papers in Chinese and English, shows BGI's links to the People's Liberation Army (PLA) include research with China's top military supercomputing experts


BusinessToday.In
January 27, 2021
The Reliance Group will purchase hundreds of COVID-19 breath testing system from the Israeli company for $15 million. The group will use them to conduct millions of tests at a cost of $10 million per month


PB Jayakumar
January 27, 2021
COVID-19 vaccine: About 19 vaccines are going to be globally available in the coming few weeks and months. Of this, about nine have already got emergency use authorisation


Reuters
January 17, 2021
COVID-19 vaccine: Pakistan, which is seeing rising numbers of coronavirus infections, said its vaccines would be procured from multiple sources


BusinessToday.In
January 12, 2021
Among these vaccines are those developed by Zydus Cadila, Biological E and Gennova, along with Russia's Sputnik-V vaccine


BusinessToday.In
January 12, 2021
Stocks to watch today on January 12:  GAIL, Tata Motors, Dr Reddy, M&M, HUL, Force Motors, Sunteck Realty among others are the top stocks to watch out for in Tuesday's trading session


Rajeev Dubey | Vivek Punj
January 11, 2021
Full authorisation-better known as \"full pre-qualification\"-is a pre-requisite to sell the vaccine in the open market or for mass immunisation of healthy individuals who are not frontline workers


BusinessToday.In
January 9, 2021
Critics have said that the country's immunisation campaign is running behind its regional peers and have questioned why the government has not moved more swiftly


Reuters
January 8, 2021
The world's second-largest economy is likely to grow 7.9% in 2021, accelerating from expected 1.9% growth in 2020, the IMF said in the conclusion of its annual economic consultation with China


BusinessToday.In
January 8, 2021
Dr Tao Lina said on the Chinese social media platform Weibo that the COVID-19 vaccine developed by Sinopharm, which is a Chinese state-run company, is extremely unsafe for use


BusinessToday.In
January 8, 2021
Bharat Biotech chairman Krishna Ella says this nasal vaccine will revolutionise Indian vaccine making capabilities and help it leapfrog along with Europe, the US and China


Rajeev Dubey
New Delhi, January 6, 2021
Dr Krishna Ella, Chairman of Bharat Biotech, said that unlike the clinical trials of AstraZeneca vaccine (which has been licensed to Serum Institute of India), Bharat Biotech did not try to suppress the side effects of vaccine by giving paracetamol to the volunteers. He also said that for his company safety came first. Watch him in conversation with Rajeev Dubey, Editor, Business Today.Also Read: China denies entry to WHO team investigating COVID-19 origins


Reuters
January 6, 2021
Governments are introducing new lockdown measures to halt the spread while facing massive demand for vaccines which are seen as the best way out of the global health crisis


BusinessToday.In
January 4, 2021
Coronavirus vaccine: China has not done any efficacy trials, Russia also has not done any efficacy trials. We are doing efficacy trials on 26,000 people in the third phase, he said


PAGES 1 OF 13  12345